BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,053,000 | +62.1% | 330,384 | -9.5% | 0.23% | -25.9% |
| Q3 2020 | $22,857,000 | -28.0% | 365,232 | -10.2% | 0.30% | +24.5% |
| Q2 2020 | $31,728,000 | -99.9% | 406,773 | 0.0% | 0.24% | +7.5% |
| Q1 2020 | $23,222,671,000 | -48.8% | 406,773 | -28.2% | 0.23% | -24.8% |
| Q4 2019 | $45,355,558,000 | +108938.3% | 566,166 | 0.0% | 0.30% | +4.5% |
| Q3 2019 | $41,596,000 | -22.1% | 566,166 | 0.0% | 0.29% | -21.0% |
| Q2 2019 | $53,406,000 | +17.8% | 566,166 | 0.0% | 0.37% | +14.3% |
| Q1 2019 | $45,321,000 | +48.5% | 566,166 | 0.0% | 0.32% | +24.4% |
| Q4 2018 | $30,522,000 | -30.9% | 566,166 | 0.0% | 0.26% | -18.6% |
| Q3 2018 | $44,194,000 | – | 566,166 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |